Home  >  News
you can get e-magazine links on WhatsApp.Click here
Pioma_Lactic
Biotechnology + Font Resize -

NBM supported National Medtech Rapid Prototyping Facility µFab opens at C-CAMP

Our Bureau, Bengaluru
Wednesday, October 6, 2021, 17:20 Hrs  [IST]

Centre for Cellular and Molecular Platforms (C-CAMP) with support from National BioPharma Mission (NBM), BIRAC has set up this national facility to specifically address the commercialization gaps faced by microfluidics technologies and medical devices developers in their idea-to-market journey.

The facility is a first-of-its-kind in India aimed at providing holistic design to pilot-scale production capabilities to entrepreneurs and innovators to enable faster product-to-market was inaugurated by Dr Renu Swarup, secretary, Department of Biotechnology and Department of Science and Technology, ministry of science and technology, Government of India, and chairperson, BIRAC in an online event.

It is envisaged to provide design and prototyping support to medtech startups in developing low-cost, rapid and point-of-care medical device solutions with applicability in healthcare, both human and animal health. It is also geared to support serological diagnostic devices, which could be a huge boost for India’s budding Covid-19 molecular diagnostics sector.

“We used to depend once on global infrastructure and global facilities. Today we can boast of state-of-the-art facilities here in India which are at par with the global ecosystem. µFab at C-CAMP is a shining example. To help the ecosystem grow from research to translation to product to commercialization, µFab will be a key factor in scaling up capabilities. We are keen on not only meeting the Nation’s demands but also to cater to global markets, said Dr Swarup.

“Our aim is to boost biopharma infrastructure in India to enhance healthcare accessibility and affordability. Diagnostics especially IVD & Point-of-Care platforms have a huge role to play. NBM supported facility µFab at C-CAMP will anchor crucial innovation developments in this area, stated Dr Subhra R. Chakrabarti, mission director, National Biopharma Mission.

Facility provides CAD design, flow simulation, prototyping, vacuum casting, injection molding, lateral flow assay printing, and packaging in CLASS10000 cleanroom facilities. It is currently in the process of acquiring ISO 13485:2016 and ICMED 13485 certifications.

Dr Taslimarif Saiyed, C-CAMP CEO & director said “With µFab we are expanding our infrastructure capabilities to further strengthen our push as catalyst for world class innovations in India. The facility is an all-in-one support system from design conceptualization to manufacturing capacity that will help cutting-edge medtech and microfluidics innovators transform their ideas to products in the market.”

Three startups: Comofi Medtech, 1008 Digital Health and Rajesh Labs, facilitated significantly by µFab in device development and pilot-scale manufacturing, presented their journeys as µFab portfolios. Advisors Dr Vijay Simha and Dr. Suresh Nair also spoke of the critical need for an all-in-one support facility like µFab in promoting the cause for more biomedical innovations.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |